DUBLIN, Calif., June 18 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Piper Jaffray Europe Conference on Wednesday, June 25, 2008 at the ANdAZ Hotel in London, England.
SuperGen’s presentation at the Piper Jaffray Europe Conference is scheduled to begin at 11:00 a.m. BST (3:00 a.m. PDT/6:00 a.m. EDT). A live webcast of the presentation will be available on the investor relations section of the Company’s Web site at www.supergen.com. A webcast replay of the presentation will be available shortly following the live event.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
CONTACT: Timothy L. Enns, SVP, Corporate Communications & Business
Development, +1-925-560-0100, tenns@supergen.com, or Mary M. Vegh, Manager,
Investor Relations, +1-925-560-2845, mary.vegh@supergen.com, both of
SuperGen, Inc.
Web site: http://www.supergen.com/
